- Supply TypeSupplier, Retailer, Distributor, Trader
- Preferred Buyer Location All over the world
ALIQOPA is indicated for the treatment of adult patients with relapsed follicular lymphoma (FL) who have received at least two prior systemic therapies. Accelerated approval was granted for this indication based on overall response rate [see Clinical Studies
View More Details